These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14661)

  • 41. Influence of thyroid function on the pharmacokinetics of gentamicin in pigs.
    Riond JL; Dix LP; Riviere JE
    Am J Vet Res; 1986 Oct; 47(10):2141-6. PubMed ID: 3777637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of propranolol isomers and their relationships with beta adrenoceptor blocking activity in rabbits administered with dl-propranolol.
    Kawashima K; Ishikawa H
    J Pharmacol Exp Ther; 1980 Jun; 213(3):628-31. PubMed ID: 6110769
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A study of practolol elimination in all grades of chronic renal failure.
    Kaye CM; Kumana CR; Franklin DA; Baker LR
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):83-8. PubMed ID: 1165145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adrenergic regulation of lipolysis in fat cells from hyperthyroid and hypothyroid patients.
    Wahrenberg H; Wennlund A; Arner P
    J Clin Endocrinol Metab; 1994 Apr; 78(4):898-903. PubMed ID: 8157718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Elimination of practolol in uremia].
    Wierzchowiecki M; Michałowska D; Tomaszkiewicz T; Maćkowiak M; Ochotny R
    Wiad Lek; 1980 May; 33(9):677-81. PubMed ID: 7405235
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of propranolol and practolol in the management of hyperthyroidism.
    Murchison LE; Bewsher PD; Chesters MI; Ferrier WR
    Br J Clin Pharmacol; 1976 Apr; 3(2):273-7. PubMed ID: 788746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The effect of thyroid gland function on beta adrenergic receptors in human lymphocytes and their membrane fractions].
    Nedvídková J; Felt V
    Cas Lek Cesk; 1984 Dec; 123(50):1531-5. PubMed ID: 6095999
    [No Abstract]   [Full Text] [Related]  

  • 48. Propranolol kinetics in hyperthyroidism [proceedings].
    Riddell JG; Neill JD; Kelly JG; McDevitt DG
    Br J Clin Pharmacol; 1979 Oct; 8(4):386P-387P. PubMed ID: 508523
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 45Ca kinetic study in patients with thyroid dysfunction.
    Yamauchi N
    Nagoya J Med Sci; 1968 Sep; 31(2):277-90. PubMed ID: 5716340
    [No Abstract]   [Full Text] [Related]  

  • 51. Adverse reactions to beta-blocking drugs: a review.
    Petrie JC; Galloway DB; Jeffers TA; Webster J
    Postgrad Med J; 1976; 52 Suppl 4():63-9. PubMed ID: 9632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on changes of beta-adrenergic receptors in polymorphonuclear cell and mononuclear cell with the changes of thyroid function.
    Lee JD; You MH; Kim YS; Kim JW; Kim KW; Kim SW; Choi YK
    Korean J Intern Med; 1986 Jan; 1(1):78-85. PubMed ID: 15759381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered plasma half-lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction.
    Vesell ES; Shapiro JR; Passananti T; Jorgensen H; Shively CA
    Clin Pharmacol Ther; 1975 Jan; 17(1):48-56. PubMed ID: 1122669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade.
    Bai SA; Abramson FP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):62-7. PubMed ID: 6129320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The rôle of catecholamines in the clinical manifestations of the hyper- and hypothyroidism syndromes].
    Perrault M; Klotz B; Robillard M
    Sem Hop; 1968 Jun; 44(30):2013-25. PubMed ID: 4300528
    [No Abstract]   [Full Text] [Related]  

  • 56. Altered pharmacokinetics of propranolol in hyperthyroidism [proceedings].
    Feely J; Crooks J; Stevenson IH
    Br J Clin Pharmacol; 1979 Oct; 8(4):387P. PubMed ID: 508524
    [No Abstract]   [Full Text] [Related]  

  • 57. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
    Sugawara K; Takami N; Ozaki M
    Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of SL 75212 and propranolol in old age, uraemia and in healthy young adults [proceedings].
    Bianchetti G; Brancaccio D; Forette F; Henry JF; Hervy MP; Ganansia J; Gomeni R; Kilborn JR; Morselli PL
    Br J Clin Pharmacol; 1980 Mar; 9(3):299P. PubMed ID: 6102472
    [No Abstract]   [Full Text] [Related]  

  • 59. Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study.
    Br Med J; 1975 Sep; 3(5986):735-40. PubMed ID: 240481
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pharmacokinetic properties of beta adrenoceptor blocking drugs.
    Gugler R
    Arch Int Pharmacodyn Ther; 1980; Suppl():27-31. PubMed ID: 6106455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.